ALTHOUGH not a binding
agreement, Roche Pharmaceuticals
has signed a letter of intent to
occupy up to 5,000 sq m office
space in the Dexus Property
Group’s The Bond Building at
Barangaroo, according to The
Australian.
With Lend Lease vacating the
space to move to Tower Three in
the International Towers Sydney
precinct, the site has attracted
interest also from rival Reckitt
Benckiser and drinks group Lion.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jul 16
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.